美國電子藥物輸送設備市場規模、佔有率、趨勢分析報告：產品、應用、細分市場預測，2025-2030

美國電子藥物傳輸設備市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，美國電子藥物輸送設備市場規模預計到2030年將達到371億美元，預測期間的複合年成長率為7.5%。

隨著糖尿病、癌症相關疼痛、神經病變疼痛等慢性疾病的治療需求日益成長，以及避孕需求的增加，電子給藥裝置 (EDDD) 產業應運而生。這些裝置提供了一種可控的給藥方法，更方便、疼痛更少，並降低了副作用的風險。 EDDD 可確保藥物濃度維持在特定範圍內（稱為治療窗），以達到最佳療效。美國癌症研究所預測，2024 年美國將新增約 2,001,140 例癌症病例。其中，乳癌仍然是女性最常見的癌症類型。

預計到2024年，美國將有2,680萬名氣喘患者，其中包括450萬名兒童，每年將導致數百萬次急診就診和數百億美元的醫療費用。此外，約有1,170萬成年人（佔4.6%）將被診斷出患有慢性阻塞性肺病）。

患者越來越傾向於在家中管理自身健康狀況，因此對能夠安全、有效、便捷地進行居家治療的藥物輸送設備的需求也隨之增加。胰島素幫浦、自動注射器、穿戴式輸液幫浦和預填充式注射器等設備已成為家庭醫療保健的必備工具，因為它們使患者能夠在極少的輔助下自行用藥，從而提供便利和自主性。

美國電子藥物輸送市場亮點

• 根據產品，植入式藥物輸送裝置 (IDDD) 部門將主導電子藥物輸送裝置產業，佔據 2024 年 33.0% 的最大收入佔有率。
• 這些設備可以每日或每月輸送藥物，減少了頻繁服藥和檢查的需要，非常適合忙碌人士。
• 預計智慧定量吸入器 (SMDI) 領域在預測期內將以 11.0% 的最快複合年成長率成長。
• 按應用分類，糖尿病領域在 2024 年佔據電子藥物傳輸設備產業的最大收益佔有率。
• 預計預測期內腫瘤學領域將以最高的複合年成長率成長。
• 癌症患者數量的增加將推動這一成長，因為這些設備為傳統注射提供了更好的替代方案，並生物有效性，使治療劑能夠直接精確地瞄準癌症組織。
• 2025年4月，雅培推出了其Proclaim DRG神經刺激系統的下一代輸送系統，預計將簡化下肢CRPS 1型和CRPS 2型患者的系統植入程序。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國電子藥物傳輸設備市場變數、趨勢與範圍

• 市場展望
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
• 商業環境分析
  • 產業分析-波特五力分析
  • PESTLE分析

第4章美國電子藥物輸送設備市場：按產品分類的業務分析

• 2024 年及 2030 年各產品市場佔有率
• 產品細分細分儀表板
• 市場規模、預測與趨勢分析（按產品，2018-2030 年）
• 智慧型輸液幫浦（輸液系統）
• 智慧定量吸入器（吸入裝置）
• 植入式藥物傳輸裝置
• 智慧經皮吸收貼片（經皮給藥系統）
• 其他

第5章美國電子藥物輸送設備市場：按應用進行的業務分析

• 2024 年及 2030 年各應用領域的市場佔有率
• 應用程式細分儀表板
• 按應用分類的市場規模、預測和趨勢分析（2018-2030 年）
• 糖尿病
• 呼吸裝置
• 腫瘤學
• 心臟病學
• 其他

第6章 競爭態勢

• 參與者概覽
• 企業市場分析
• 公司分類
• 戰略地圖
• 公司簡介/上市公司
  • Medtronic
  • BD
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Johnson &Johnson Services, Inc.
  • United Therapeutics Corporation
  • Abbott
  • AstraZeneca

U.S. Electronic Drug Delivery Devices Market Growth & Trends:

The U.S. electronic drug delivery devices market size is anticipated to reach USD 37.1 billion by 2030, growing at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The growing demand for managing chronic conditions like diabetes, cancer-related pain, neuropathic pain, and contraceptive needs has contributed to the rise of the Electronic Drug Delivery Devices (EDDD) industry. These devices provide a controlled method of drug administration that is both more convenient and less painful, while also reducing the risk of side effects. They help ensure that drug levels remain within a specific range, known as the therapeutic window, for optimal effectiveness. The National Cancer Institute forecasts that around 2,001,140 new cancer cases will be diagnosed in the U.S. in 2024. Among these, breast cancer remains the most frequently diagnosed type of cancer in women.

In 2024, an estimated 26.8 million Americans were affected by asthma, including 4.5 million children. This contributes to millions of emergency department visits annually, resulting in tens of billions of dollars in healthcare expenses. In addition, approximately 11.7 million people, or 4.6% of adults, have been diagnosed with chronic obstructive pulmonary disease (COPD).

Patients increasingly prefer managing their health conditions at home, so there is a growing demand for drug delivery devices that enable safe, effective, and easy at-home treatments. Devices such as insulin pumps, auto-injectors, wearable infusion pumps, and pre-filled syringes are becoming indispensable tools in home healthcare because they allow patients to self-administer medications with minimal assistance, offering convenience and autonomy.

U.S. Electronic Drug Delivery Devices Market Highlights

• Based on product, the Implantable Drug Delivery Devices (IDDD) segment dominated the electronic drug delivery devices industry, accounting for the largest revenue share of 33.0% in 2024.
• These devices enable daily and monthly drug delivery, reducing the need for frequent dosing and checkups, making them ideal for busy individuals.
• The Smart Metered Dose Inhalers (SMDIs) segment is expected to grow at the fastest CAGR of 11.0% over the forecast period.
• Based on application, the diabetes segment led the electronic drug delivery devices industry with the largest revenue share in 2024.
• The oncology segment is estimated to grow at the largest CAGR over the forecast period.
• The rising number of cancer cases fuels the growth as these devices offer a superior alternative to traditional injections, revolutionizing drug delivery by effectively improving the bioavailability and enabling precise targeting of therapeutic agents directly to cancerous tissues.
• In April 2025, Abbott introduced a next-generation delivery system for its Proclaim DRG neurostimulation system. The system is expected to streamline the procedure for implanting a system in patients suffering from CRPS Type 1 and CRPS Type 2 of the lower extremities.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Electronic Drug Delivery Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Electronic Product Delivery Devices Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Smart Infusion Pumps (Infusion Systems)
  • 4.4.1. Smart Infusion Pumps (Infusion Systems) Market, 2018 - 2030 (USD Million)
  • 4.4.2. Non-Biologic Smart Infusion Systems
    • 4.4.2.1. Non-Biologic Smart Infusion Systems Market, 2018 - 2030 (USD Million)
  • 4.4.3. Biologic Smart Infusion Systems
    • 4.4.3.1. Biologic Smart Infusion Systems Market, 2018 - 2030 (USD Million)
    • 4.4.3.2. Smart Infusion Insulin Pumps
      • 4.4.3.2.1. Smart Infusion Insulin Pumps Market, 2018 - 2030 (USD Million)
    • 4.4.3.3. Other
      • 4.4.3.3.1. Other Market, 2018 - 2030 (USD Million)
• 4.5. Smart Metered Dose Inhalers (Inhalation Devices)
  • 4.5.1. Smart Metered Dose Inhalers (Inhalation Devices) Market, 2018 - 2030 (USD Million)
• 4.6. Implantable Drug Delivery Devices
  • 4.6.1. Implantable Drug Delivery Devices Market, 2018 - 2030 (USD Million)
  • 4.6.2. Biologic Implantable Drug Delivery Devices
    • 4.6.2.1. Biologic Implantable Drug Delivery Devices Market, 2018 - 2030 (USD Million)
  • 4.6.3. Non-Biologic Implantable Drug Delivery Devices
    • 4.6.3.1. Non-Biologic Implantable Drug Delivery Devices Market, 2018 - 2030 (USD Million)
• 4.7. Smart Transdermal Patches (Transdermal Delivery Systems)
  • 4.7.1. Smart Transdermal Patches (Transdermal Delivery Systems) Market, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Electronic Drug Delivery Devices Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Diabetes
  • 5.4.1. Electronic Drug Delivery Devices Market, for Diabetes, 2018 - 2030 (USD Million)
• 5.5. Respiratory Devices
  • 5.5.1. Electronic Drug Delivery Devices Market, for Respiratory Devices, 2018 - 2030 (USD Million)
• 5.6. Oncology
  • 5.6.1. Electronic Drug Delivery Devices Market, for Oncology, 2018 - 2030 (USD Million)
• 5.7. Cardiology
  • 5.7.1. Electronic Drug Delivery Devices Market, for Cardiology, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Electronic Drug Delivery Devices Market, for Others, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. Medtronic
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial Performance
    • 6.5.1.3. Product Benchmarking
    • 6.5.1.4. Strategic Initiatives
  • 6.5.2. BD
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial Performance
    • 6.5.2.3. Product Benchmarking
    • 6.5.2.4. Strategic Initiatives
  • 6.5.3. Insulet Corporation
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial Performance
    • 6.5.3.3. Product Benchmarking
    • 6.5.3.4. Strategic Initiatives
  • 6.5.4. Tandem Diabetes Care, Inc.
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial Performance
    • 6.5.4.3. Product Benchmarking
    • 6.5.4.4. Strategic Initiatives
  • 6.5.5. Eli Lilly and Company
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial Performance
    • 6.5.5.3. Product Benchmarking
    • 6.5.5.4. Strategic Initiatives
  • 6.5.6. Novo Nordisk A/S
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial Performance
    • 6.5.6.3. Product Benchmarking
    • 6.5.6.4. Strategic Initiatives
  • 6.5.7. Johnson & Johnson Services, Inc.
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial Performance
    • 6.5.7.3. Product Benchmarking
    • 6.5.7.4. Strategic Initiatives
  • 6.5.8. United Therapeutics Corporation
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial Performance
    • 6.5.8.3. Product Benchmarking
    • 6.5.8.4. Strategic Initiatives
  • 6.5.9. Abbott
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial Performance
    • 6.5.9.3. Product Benchmarking
    • 6.5.9.4. Strategic Initiatives
  • 6.5.10. AstraZeneca
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial Performance
    • 6.5.10.3. Product Benchmarking
    • 6.5.10.4. Strategic Initiatives

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. U.S. electronic drug delivery devices market, by product, 2018 - 2030 (USD Million)
• Table 4. U.S. electronic drug delivery devices market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 U.S. electronic drug delivery devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Product outlook (USD Million)
• Fig. 9 Application outlook (USD Million)
• Fig. 10 Competitive landscape
• Fig. 11 U.S. electronic drug delivery devices market dynamics
• Fig. 12 U.S. electronic drug delivery devices market: Porter's five forces analysis
• Fig. 13 U.S. electronic drug delivery devices market: Pestle analysis
• Fig. 14 U.S. electronic drug delivery devices market: Product segment dashboard
• Fig. 15 U.S. electronic drug delivery devices market: Product market share analysis, 2024 & 2030
• Fig. 16 Smart infusion pumps (infusion systems) market, 2018 - 2030 (USD Million)
• Fig. 17 Non-biologic smart infusion systems market, 2018 - 2030 (USD Million)
• Fig. 18 Biologic Smart Infusion Systems market, 2018 - 2030 (USD Million)
• Fig. 19 Smart Infusion Insulin Pumps market, 2018 - 2030 (USD Million)
• Fig. 20 Others market, 2018 - 2030 (USD Million)
• Fig. 21 Smart metered dose inhalers (inhalation devices) market, 2018 - 2030 (USD Million)
• Fig. 22 Implantable Drug Delivery Devices market, 2018 - 2030 (USD Million)
• Fig. 23 Biologic implantable drug delivery devices market, 2018 - 2030 (USD Million)
• Fig. 24 Non-Biologic Implantable Drug Delivery Devices market, 2018 - 2030 (USD Million)
• Fig. 25 Smart transdermal patches (transdermal delivery systems) market, 2018 - 2030 (USD Million)
• Fig. 26 Others market, 2018 - 2030 (USD Million)
• Fig. 27 U.S. electronic drug delivery devices market: Application segment dashboard
• Fig. 28 U.S. electronic drug delivery devices market: Application market share analysis, 2024 & 2030
• Fig. 29 Electronic drug delivery devices market, for diabetes, 2018 - 2030 (USD Million)
• Fig. 30 Electronic drug delivery devices market, for respiratory devices, 2018 - 2030 (USD Million)
• Fig. 31 Electronic drug delivery devices market, for oncology, 2018 - 2030 (USD Million)
• Fig. 32 Electronic drug delivery devices market, for cardiology, 2018 - 2030 (USD Million)
• Fig. 33 Electronic drug delivery devices market, for others, 2018 - 2030 (USD Million)
• Fig. 34 Company categorization
• Fig. 35 Company market position analysis
• Fig. 36 Strategic framework